|Cynthia L. Comella, MD, FAAN
||Dr. Comella has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz Pharmaceutical, Revance Therapeutic, Retrophin Therapeutic. She receives compensation/honoraria for services as a consultant or an advisory committee member: Acorda Therapeutics, Allergan, Inc;; Lundbeck Ltd.;Medtronic Inc.; Merz Pharmaceuticals;Acadia Pharmaceuticals; Jazz Pharmaceuticals, Neurocrine Biosciences Inc., Revance Therapeutic. She receives royalties from Cambridge, Wolters Kluwer. . Dr. Comella has received research support from Acorda, Revance, Merz, Eisai.
|Deborah Hall, MD, PhD, FAAN
||Dr. Hall has received personal compensation in an editorial capacity for American Academy of Neurology . Dr. Hall has received research support from Neurocrine, Pfizer, and Abbvie.